https://www.selleckchem.com/pr....oducts/Dasatinib.htm
The aim of this study is to investigate the association between adherence to beta-blocker treatment after a first acute myocardial infarction (AMI) and long-term risk of heart failure (HF) and death. All patients admitted for a first AMI included in the nationwide Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies register between 2005 and 2010 were eligible (n=71638). After exclusion of patients who died in-hospital, patients with previous HF, patien
כמו
תגובה
לַחֲלוֹק
